Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease.
about
Cardiac PET perfusion: prognosis, risk stratification, and clinical managementCardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease.Assessment of myocardial perfusion and function with PET and PET/CT.Diagnostic value of SPECT, PET and PET/CT in the diagnosis of coronary artery disease: A systematic reviewDiagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts?Myocardial perfusion scintigraphy: past, present and futurePrognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.Quantitative cardiac positron emission tomography: the time is coming!Prognostic value of treadmill exercise and dobutamine stress positron emission tomographyIncremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEFImaging as an End Point in Ischemia Trials.PET and PET/CT in cardiovascular disease.Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging.Nuclear perfusion imaging for functional evaluation of patients with known or suspected coronary artery disease: the future is now.Diagnosing coronary artery disease with hybrid PET/CT: it takes two to tango.New insights from major prospective cohort studies with cardiac nuclear imaging.Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease.Proceedings of the ASNC Cardiac PET Summit, 12 May 2014, Baltimore, MD : 1: The value of PET: Integrating cardiovascular PET into the care continuum.Current and future trends in multimodality imaging of coronary artery disease.Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.Prognostic value of normal positron emission tomography myocardial perfusion imaging in patients with known or suspected coronary artery disease: a meta-analysis.The role of positron emission tomography in the evaluation of myocardial ischemia in women.Current perspectives in coronary microvascular dysfunction.Prognosis of a normal positron emission tomography 82Rb myocardial perfusion imaging study in women with no history of coronary disease.Prognostic value of positron emission tomography myocardial perfusion imaging beyond traditional cardiovascular risk factors: Systematic review and meta-analysis.Analytic system matrix resolution modeling in PET: an application to Rb-82 cardiac imaging.Comparison of low-pitch and respiratory-averaged CT protocols for attenuation correction of cardiac PET studies.The prognosis for prognosis remains excellent.Evaluating the prognostic value of positron-emission tomography myocardial perfusion imaging using automated software to calculate perfusion defect size.Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients.Should we use more PET-CT in clinical cardiology?Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era.
P2860
Q26852383-9CE4E887-CAEB-41B6-BBC3-01A953D9C30DQ33688206-395F6065-E6A6-4CB2-95F4-85B35DB859C3Q33854906-E73F5C12-1E46-4799-A122-1843FC44458DQ35691887-A4F1CD5F-65D0-44B1-A24A-0248FE7FADABQ35773021-B4B0BC74-6BD1-4E16-88E7-55222B8897F8Q36325479-0B45A8F0-54FC-4B37-9FA4-29C584655E39Q36546752-5C87ED8A-FA39-4C69-AF7F-2F6C0D87DA10Q37288099-C17E46BD-AEC7-4270-8567-8A335701C7EFQ37295184-693A4499-4433-445C-98C0-46CE3A34B937Q37637823-3D302E5A-3CC9-4E34-BE56-601EAA1C720BQ37863002-3262214B-1C39-44DA-8630-D715FC5E2D48Q37896144-F24AF459-C0EF-4F48-BEBA-88581ECA491BQ37965658-94239159-62C5-4C7A-9C97-3DA61B430DA3Q38032620-166D2F15-0B3E-43B8-97D0-70ED1A644212Q38120658-71EB075B-FAEF-4367-8C8A-8E7CC7586121Q38197125-DA3DF3B1-E226-4E7C-BA5D-725F572FB571Q38263600-620D1FA0-42DD-40D8-856D-6CE68E4706E1Q38439405-539910B1-DF8E-4603-978C-6B9D1CF66107Q38442451-098D940E-AAFB-48EA-937D-45902061E408Q38741610-7CED7D88-EAB6-4183-BAED-2A4CCB022E33Q38901252-5AC39724-9F00-4512-9B29-96D393D1B4A2Q38917554-D55CBA5C-C6D7-4D62-8715-0705FA6B7554Q39038913-939FB843-1432-445C-AD3F-CBC6909ADD44Q39775819-52CD655F-AE72-4E1C-9A5D-DE4AF89DB0FAQ40964410-C1435A34-D251-4644-830B-DB3CD02BF2FDQ41840388-12655379-BE8B-44A4-B205-7480C8719ABDQ46033437-F67924D3-A24D-41D1-A398-0A5B4D5212B1Q46790828-8A2008AC-9920-42E0-93C1-EC383A314C42Q47286597-ECDFE978-2DB3-4C8F-8896-2E19131F0152Q53081418-455F941B-4D62-4753-BFD8-91C6F25C4BD8Q53431311-357A48EF-3B13-45C9-B92E-C728EB74F5EDQ55383701-F1F291E3-63E6-4F6C-81A5-C60C9CC7A105
P2860
Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Incremental value of rubidium- ...... ected coronary artery disease.
@en
type
label
Incremental value of rubidium- ...... ected coronary artery disease.
@en
prefLabel
Incremental value of rubidium- ...... ected coronary artery disease.
@en
P2093
P1476
Incremental value of rubidium- ...... ected coronary artery disease.
@en
P2093
P304
P356
10.1016/S0002-9149(97)00537-7
P407
P577
1997-10-01T00:00:00Z